Skip to main content
. 2017 Sep 11;72(Suppl 2):i20–i23. doi: 10.1093/jac/dkx303

Figure 2.

Figure 2.

Efficacy of the ethambutol/azithromycin standard regimen in the MAC-HFS. The two-drug combination standard therapy failed to kill intracellular MAC beyond day 7.